IDNA holdings
iShares Genomics Immunology and Healthcare ETF
Positions
61 stored of 61 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY | US0669225197 | 066922519 | 10.392% | $19.8M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 2 | Bayer Aktiengesellschaft BAYER AG | DE000BAY0017 | Not reported | 4.812% | $9.2M | Equity (common) | Corporate | Germany | EUR |
| 3 | Twist Bioscience Corp | US90184D1000 | 90184D100 | 4.794% | $9.1M | Equity (common) | Corporate | United States | USD |
| 4 | REVOLUTION MEDICINES, INC. | US76155X1000 | 76155X100 | 4.554% | $8.7M | Equity (common) | Corporate | United States | USD |
| 5 | REGENERON PHARMACEUTICALS, INC. | US75886F1075 | 75886F107 | 4.350% | $8.3M | Equity (common) | Corporate | United States | USD |
| 6 | GENMAB A/S | DK0010272202 | Not reported | 4.233% | $8.1M | Equity (common) | Corporate | Denmark | DKK |
| 7 | INCYTE CORPORATION | US45337C1027 | 45337C102 | 4.231% | $8.1M | Equity (common) | Corporate | United States | USD |
| 8 | MODERNA, INC. | US60770K1079 | 60770K107 | 4.188% | $8.0M | Equity (common) | Corporate | United States | USD |
| 9 | Takeda Pharmaceutical Company Limited TAKEDA PHARMACEUTICAL CO LTD | JP3463000004 | Not reported | 4.049% | $7.7M | Equity (common) | Corporate | Japan | JPY |
| 10 | MERCK & CO., INC. | US58933Y1055 | 58933Y105 | 3.907% | $7.5M | Equity (common) | Corporate | United States | USD |
| 11 | VERTEX PHARMACEUTICALS INCORPORATED | US92532F1003 | 92532F100 | 3.870% | $7.4M | Equity (common) | Corporate | United States | USD |
| 12 | Roche Holding AG | CH1499059983 | Not reported | 3.846% | $7.3M | Equity (common) | Corporate | Switzerland | CHF |
| 13 | IPSEN SA | FR0010259150 | Not reported | 3.840% | $7.3M | Equity (common) | Corporate | France | EUR |
| 14 | BioNTech SE | US09075V1026 | 09075V102 | 3.727% | $7.1M | Other | Corporate | Germany | USD |
| 15 | EXELIXIS, INC. | US30161Q1040 | 30161Q104 | 3.647% | $7.0M | Equity (common) | Corporate | United States | USD |
| 16 | GSK PLC | GB00BN7SWP63 | Not reported | 3.633% | $6.9M | Equity (common) | Corporate | United Kingdom | GBP |
| 17 | SANOFI SA | FR0000120578 | Not reported | 3.464% | $6.6M | Equity (common) | Corporate | France | EUR |
| 18 | IDEAYA Biosciences Inc | US45166A1025 | 45166A102 | 3.357% | $6.4M | Equity (common) | Corporate | United States | USD |
| 19 | Immunitybio Inc | US45256X1037 | 45256X103 | 3.070% | $5.9M | Equity (common) | Corporate | United States | USD |
| 20 | ARCUS BIOSCIENCES, INC. | US03969F1093 | 03969F109 | 2.685% | $5.1M | Equity (common) | Corporate | United States | USD |
| 21 | CARIS LIFE SCIENCES, INC. | US1421521071 | 142152107 | 2.185% | $4.2M | Equity (common) | Corporate | United States | USD |
| 22 | ONO PHARMACEUTICAL CO., LTD. | JP3197600004 | Not reported | 1.914% | $3.7M | Equity (common) | Corporate | Japan | JPY |
| 23 | Iovance Biotherapeutics Inc | US4622601007 | 462260100 | 1.795% | $3.4M | Equity (common) | Corporate | United States | USD |
| 24 | NUVATION BIO INC. | US67080N1019 | 67080N101 | 1.779% | $3.4M | Equity (common) | Corporate | United States | USD |
| 25 | CRISPR Therapeutics AG | CH0334081137 | H17182108 | 1.565% | $3.0M | Equity (common) | Corporate | Switzerland | USD |
| 26 | ABCELLERA BIOLOGICS INC. | CA00288U1066 | 00288U106 | 1.523% | $2.9M | Equity (common) | Corporate | Canada | USD |
| 27 | Vir Biotechnology Inc | US92764N1028 | 92764N102 | 1.312% | $2.5M | Equity (common) | Corporate | United States | USD |
| 28 | NOVAVAX, INC. | US6700024010 | 670002401 | 1.303% | $2.5M | Equity (common) | Corporate | United States | USD |
| 29 | Janux Therapeutics Inc | US47103J1051 | 47103J105 | 0.987% | $1.9M | Equity (common) | Corporate | United States | USD |
| 30 | Sunshine Lake Pharma Co Ltd | CNE1000070M8 | Y8243F109 | 0.982% | $1.9M | Equity (common) | Corporate | China | HKD |
| 31 | Corvus Pharmaceuticals Inc | US2210151005 | 221015100 | 0.952% | $1.8M | Equity (common) | Corporate | United States | USD |
| 32 | Personalis Inc | US71535D1063 | 71535D106 | 0.892% | $1.7M | Equity (common) | Corporate | United States | USD |
| 33 | Kura Oncology Inc | US50127T1097 | 50127T109 | 0.880% | $1.7M | Equity (common) | Corporate | United States | USD |
| 34 | GenFleet Therapeutics (Shanghai) Inc | CNE1000074L2 | Y2S2YD109 | 0.776% | $1.5M | Equity (common) | Corporate | China | HKD |
| 35 | RIGEL PHARMACEUTICALS, INC. | US7665597024 | 766559702 | 0.748% | $1.4M | Equity (common) | Corporate | United States | USD |
| 36 | CytomX Therapeutics Inc | US23284F1057 | 23284F105 | 0.611% | $1.2M | Equity (common) | Corporate | United States | USD |
| 37 | VERASTEM, INC. | US92337C2035 | 92337C203 | 0.543% | $1.0M | Equity (common) | Corporate | United States | USD |
| 38 | Alvotech SA | LU2458332611 | L01800108 | 0.529% | $1.0M | Equity (common) | Corporate | Luxembourg | USD |
| 39 | Design Therapeutics Inc | US25056L1035 | 25056L103 | 0.522% | $996K | Equity (common) | Corporate | United States | USD |
| 40 | Xencor Inc | US98401F1057 | 98401F105 | 0.515% | $984K | Equity (common) | Corporate | United States | USD |
| 41 | INTELLIA THERAPEUTICS, INC. | US45826J1051 | 45826J105 | 0.514% | $981K | Equity (common) | Corporate | United States | USD |
| 42 | Shanghai Henlius Biotech Inc | CNE100003N76 | Not reported | 0.505% | $964K | Equity (common) | Corporate | China | HKD |
| 43 | OCUGEN, INC. | US67577C1053 | 67577C105 | 0.466% | $890K | Equity (common) | Corporate | United States | USD |
| 44 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | US69404D1081 | 69404D108 | 0.456% | $871K | Equity (common) | Corporate | United States | USD |
| 45 | VALNEVA SE | FR0004056851 | Not reported | 0.454% | $866K | Equity (common) | Corporate | France | EUR |
| 46 | Ginkgo Bioworks Holdings Inc | US37611X2099 | 37611X209 | 0.429% | $820K | Equity (common) | Corporate | United States | USD |
| 47 | AbClon Inc. | KR7174900001 | Y0R0KQ104 | 0.246% | $470K | Equity (common) | Corporate | South Korea | KRW |
| 48 | Prime Medicine, Inc | US74168J1016 | 74168J101 | 0.100% | $191K | Equity (common) | Corporate | United States | USD |
| 49 | BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares BLACKROCK CASH FUNDS TREASURY | US0669224778 | 066922477 | 0.093% | $178K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 50 | JAPANESE YEN | Not reported | Not reported | 0.037% | $72K | Other | Other | Japan | JPY |
| 51 | GREAT BRITISH POUND | Not reported | Not reported | 0.031% | $58K | Other | Other | United Kingdom | GBP |
| 52 | XAV HEALTH CARE SEP26 | Not reported | Not reported | 0.013% | $26K | Equity derivatives | Other | United States | USD |
| 53 | KOREAN WON | Not reported | Not reported | 0.008% | $15K | Other | Other | South Korea | KRW |
| 54 | DANISH KRONER | Not reported | Not reported | 0.007% | $14K | Other | Other | Denmark | DKK |
| 55 | ARCELLX INC CVR | US039CVR0142 | 039CVR014 | 0.003% | $5K | Equity (common) | Other | United States | USD |
| 56 | HONG KONG DOLLAR | Not reported | Not reported | 0.002% | $4K | Other | Other | Hong Kong | HKD |
| 57 | SWISS FRANC | Not reported | Not reported | <0.001% | $860 | Other | Other | Switzerland | CHF |
| 58 | EURO | Not reported | Not reported | <0.001% | $763 | Other | Other | Not stated or supranational | EUR |
| 59 | NEW TAIWAN DOLLAR | Not reported | Not reported | <0.001% | $162 | Other | Other | Taiwan | TWD |
| 60 | OMNIAB INC | US68218J3014 | 68218J301 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |
| 61 | OMNIAB INC | US68218J2024 | 68218J202 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |